GALAXY-2 trial: A randomized phase III study of ganetespib in combination with docetaxel versus docetaxel alone in patients with advanced non-small cell lung adenocarcinoma.
Dean Anthony Fennell
Consultant or Advisory Role - Synta
Honoraria - Synta
Research Funding - Synta
Glenwood D. Goss
Consultant or Advisory Role - Synta (U)
Mark A. Socinski
Honoraria - Synta
Research Funding - Synta
Kazuhiko Nakagawa
Honoraria - Synta
Joan H. Schiller
Research Funding - Synta
Philip Bonomi
Consultant or Advisory Role - Synta (U)
Honoraria - Synta
Vera Hirsh
No relevant relationships to disclose
Karen Kelly
No relevant relationships to disclose
James F. Spicer
Research Funding - Guys and St. Thomas Hospital
Rafael Rosell
No relevant relationships to disclose
Bojan Zaric
Consultant or Advisory Role - Synta
Honoraria - Synta
Other Remuneration - Synta
Tudor-Eliade Ciuleanu
No relevant relationships to disclose
Vojislav M. Vukovic
Employment or Leadership Position - Synta
Stock Ownership - Synta
Florentina Teofilovici
Employment or Leadership Position - Synta
Stock Ownership - Synta
Iman El-Hariry
Employment or Leadership Position - Synta
Stock Ownership - Synta
Wei Guo
Employment or Leadership Position - Synta
Stock Ownership - Synta
Suresh S. Ramalingam
Consultant or Advisory Role - Synta (U)